Olanzapine and blood creatine phosphokinase increased 
Olanzapine and blood creatine phosphokinase increased Patient Reports February 12, 2012
Olanzapine Side Effects Report #5337983-1
Olanzapine side effect was reported by a Physician from SPAIN on May 17, 2007. Female patient, 58 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood glucose increased, electrocardiogram qt prolonged, heart rate increased, leukocytosis, loss of consciousness, metabolic acidosis, overdose. Olanzapine dosage: unknown. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5352843-8
Olanzapine side effect was reported by a Physician from SPAIN on June 01, 2007. Female patient, 58 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood glucose increased, electrocardiogram qt prolonged, intentional overdose, leukocytosis, loss of consciousness, metabolic acidosis. Olanzapine dosage: unknown. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #4822104-1
Olanzapine side effect was reported by a Pharmacist from NETHERLANDS on Oct 17, 2005. Male patient, 39 years of age, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, myalgia, neuroleptic malignant syndrome. Olanzapine dosage: 20 MG/1 DAY. During the same period patient was treated with PANTOPRAZOLE, PROMETHAZINE, OXAZEPAM. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #4870677-5
Olanzapine side effect was reported by a Pharmacist from NETHERLANDS on Dec 02, 2005. Male patient, 39 years of age, was diagnosed with schizophrenia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myalgia. Olanzapine dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PROMETHAZINE, OXAZEPAM. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5646358-7
Olanzapine side effect was reported by a Physician from CZECH REPUBLIC on Feb 25, 2008. Male patient, 28 years of age, was diagnosed with schizophrenia, extrapyramidal disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood urea increased, brain oedema, cardiac arrest
, condition aggravated, cyanosis. Olanzapine dosage: 30 MG, DAILY (1/D). During the same period patient was treated with SEROQUEL, ZOLOFT, AKINETON. Patient was hospitalized. Patient died on 07/08/2007.Olanzapine Side Effects Report #5576436-2
Olanzapine side effect was reported by a Physician from CZECH REPUBLIC on Dec 19, 2007. Female patient, 31 years of age, was diagnosed with schizoaffective disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: agitation, blood creatine phosphokinase increased, depressed level of consciousness, hyperhidrosis, muscle rigidity, neuroleptic malignant syndrome, psychotic disorder
, pyrexia. Olanzapine dosage: 5 MG, DAILY (1/D). During the same period patient was treated with HALOPERIDOL. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #4692390-X
Olanzapine side effect was reported by a Physician from on June 01, 2005. Female patient, 74 years of age, was diagnosed with psychotic disorder
and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood amylase increased, blood calcium increased, blood creatine phosphokinase increased, dementia alzheimer's type, depression , disease recurrence, lipase increased. Olanzapine dosage: 5MG/1 DAY. During the same period patient was treated with VENLAFAXINE, MIRTAZAPINE, GALANTAMINE. Patient recovered.Olanzapine Side Effects Report #4680417-0
Olanzapine side effect was reported by a Physician from on May 12, 2005. Female patient, 74 years of age, was diagnosed with mental disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood amylase increased, blood calcium increased, blood creatine phosphokinase increased, lipase increased. Olanzapine dosage: 5 MG/1 DAY. During the same period patient was treated with VENLAFAXINE, MIRTAZAPINE, GALANTAMIN. Patient recovered.
Olanzapine Side Effects Report #5232477-6
Olanzapine side effect was reported by a Physician from UNITED KINGDOM on Jan 26, 2007. Female patient, 35 years of age, weighting 187.4 lb, was diagnosed with mania and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood amylase increased, blood creatine phosphokinase increased, diabetic ketoacidosis, multi-organ failure. Olanzapine dosage: 10 MG, EACH EVENING. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #4771051-2
Olanzapine side effect was reported by a Consumer or non-health professional from SWITZERLAND on Aug 26, 2005. Female patient, 74 years of age, was diagnosed with depression
and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood amylase increased, blood creatine phosphokinase increased, lipase increased. Olanzapine dosage: 5 MG. During the same period patient was treated with EFFEXOR, MIRTAZAPINE, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #4564598-5
Olanzapine side effect was reported by a Physician from on Jan 06, 2005. Female patient, 44 years of age, was diagnosed with depression
and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatine phosphokinase increased, blood creatinine increased, blood sodium decreased, cardiac failure, cardiomyopathy , hepatic failure, hepatic necrosis, multi-organ failure. Olanzapine dosage: 10 MG. During the same period patient was treated with DIAZEPAM, PROMAZINE, DOTHIEPIN HYDROCHLORIDE, ZOPICLONE. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #5630217-X
Olanzapine side effect was reported by a Physician from GERMANY on Feb 08, 2008. Female patient, weighting 138.9 lb, was diagnosed with depression
and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, c-reactive protein increased, depressive delusion, hypothermia , inappropriate antidiuretic hormone secretion, neuroleptic malignant syndrome. Olanzapine dosage: 15 MG, EACH EVENING. During the same period patient was treated with SEROQUEL, DOMINAL, ESTRADIOL VALERATE, EUTHYROX, TAVOR, JATROSOM. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #4823286-8
Olanzapine side effect was reported by a Physician from ITALY on Oct 17, 2005. Male patient, 65 years of age, weighting 154.3 lb, was diagnosed with bipolar disorder
and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, myocarditis, myopathy, renal failure acute. Olanzapine dosage: unknown. During the same period patient was treated with LAMOTRIGINE, SERTRALINE, ENALAPRIL, TICLOPIDINE, DOXAZOSIN. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #4765786-5
Olanzapine side effect was reported by a Consumer or non-health professional from SPAIN on Aug 18, 2005. Male patient, 58 years of age, weighting 220.5 lb, was diagnosed with bipolar disorder
and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, csf protein increased, demyelination, gamma-glutamyltransferase increased, hypersensitivity, neuropathy peripheral, rash . Olanzapine dosage: 5 MG DAY. During the same period patient was treated with CLONAZEPAM, VALPROIC ACID, PREDNISONE, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #4767646-2
Olanzapine side effect was reported by a Consumer or non-health professional from SPAIN on Sept 02, 2005. Male patient, 58 years of age, weighting 220.5 lb, was diagnosed with bipolar disorder
and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, demyelinating polyneuropathy, gamma-glutamyltransferase increased, hypersensitivity. Olanzapine dosage: 5 MG DAY. During the same period patient was treated with CLONAZEPAM, VALPROIC ACID, PREDNISONE, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #5020157-1
Olanzapine side effect was reported by a Consumer or non-health professional from CHILE on May 12, 2006. Female patient, 15 years of age, was diagnosed with asperger's disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, inflammation, muscle strain, renal impairment. Olanzapine dosage: 14 MG. During the same period patient was treated with VALPROIC ACID, SERTRALINE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #4770986-4
Olanzapine side effect was reported by a Physician from SWITZERLAND on Aug 19, 2005. Female patient, 20 years of age, weighting 88.18 lb, was diagnosed with anxiety disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: anoxic encephalopathy, arrhythmia
, blood creatine phosphokinase increased, brain herniation, brain oedema, confusional state, electrocardiogram qt corrected interval prolonged, fall . Olanzapine dosage: 5 MG DAY. Patient was hospitalized. Patient died.Olanzapine Side Effects Report #4806786-6
Olanzapine side effect was reported by a Physician from SWITZERLAND on Sept 30, 2005. Female patient, 20 years of age, weighting 88.18 lb, was diagnosed with anxiety disorder and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: anoxic encephalopathy, blood creatine phosphokinase increased, brain herniation, brain oedema, confusional state, csf test abnormal, disease progression, electrocardiogram qt corrected interval prolonged, grand mal convulsion. Olanzapine dosage: 5 MG DAY. Patient was hospitalized. Patient died on 02/27/2005.
Olanzapine Side Effects Report #4623126-6
Olanzapine side effect was reported by a Health Professional from on Mar 28, 2005. Male patient, 70 years of age, weighting 171.3 lb, was diagnosed with agitation and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: arrhythmia
, blood creatine phosphokinase increased, blood pressure abnormal, dehydration, feeling abnormal, fluid intake reduced, hyperhidrosis, hyperpyrexia, lethargy. Olanzapine dosage: 15 MG OVER 4 HOURS ORAL. During the same period patient was treated with HALOPERIDOL, PRAMIPEXOLE, SELEGILINE, CARBIDOPA AND LEVODOPA, GLYBURIDE, LISINOPRIL, DILTIAZEM, DIGOXIN. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #4771047-0
Olanzapine side effect was reported by a Physician from NETHERLANDS on Aug 29, 2005. Female patient, 82 years of age, weighting 121.3 lb, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, extrapyramidal disorder, pyrexia, urinary retention, urosepsis. Olanzapine dosage: 10 MG/1 DAY. During the same period patient was treated with AMOXICILLIN W, MOVICOLON. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #4918563-6
Olanzapine side effect was reported by a Pharmacist from UNITED STATES on Feb 21, 2006. Male patient, 67 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: apnoea, blood creatine phosphokinase increased, depressed level of consciousness, fall
, hypoxia, neuroleptic malignant syndrome, oxygen saturation decreased, pulmonary embolism , pyrexia. Olanzapine dosage: 10 MG TID PO. During the same period patient was treated with TRAZODONE. Patient died.Olanzapine Side Effects Report #5885637-5
Olanzapine side effect was reported by a Physician from UNITED KINGDOM on Sept 02, 2008. Female patient, 50 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: areflexia, blood creatine phosphokinase increased, body temperature increased, coma, overdose, respiratory depression. Olanzapine dosage: 700 MG, ONCE/SINGLE, ORAL; 20 MG, QD, ORAL. During the same period patient was treated with DIAZEPAM, PROPRANOLOL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #4906962-8
Olanzapine side effect was reported by a Physician from JAPAN on Jan 23, 2006. Male patient, 47 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, c-reactive protein increased, catatonia, catheter sepsis, decubitus ulcer, haematemesis, hyperhidrosis, hypoproteinaemia. Olanzapine dosage: 15MG, DAILY (1/D), UNK. During the same period patient was treated with RISPERIDONE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #4679540-6
Olanzapine side effect was reported by a Physician from on May 25, 2005. Male patient, 41 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mm, constipation
, dermatomyositis, muscle rigidity, muscular weakness. Olanzapine dosage: 20 MG/D. During the same period patient was treated with STEROIDS NOS, CLOZARIL. Patient recovered.Olanzapine Side Effects Report #4704866-7
Olanzapine side effect was reported by a Physician from NEW ZEALAND on May 25, 2005. Male patient, 41 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mm, constipation
, dermatomyositis, muscle rigidity, muscular weakness. Olanzapine dosage: 20 MG/D. During the same period patient was treated with PREDNISONE, CLOZARIL. Patient recovered.Olanzapine Side Effects Report #4838877-8
Olanzapine side effect was reported by a Physician from NEW ZEALAND on May 25, 2005. Male patient, 41 years of age, was diagnosed with dermatomyositis, schizophrenia, paranoid type and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mm, constipation
, dermatomyositis, muscle rigidity, muscular weakness. Olanzapine dosage: 20 MG/D. During the same period patient was treated with PREDNISONE, CLOZARIL. Patient recovered.Olanzapine Side Effects Report #5254808-3
Olanzapine side effect was reported by a Physician from UNITED KINGDOM on Feb 19, 2007. Male patient, 35 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, intentional overdose, serotonin syndrome. Olanzapine dosage: 840 MG, UNK. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5690016-X
Olanzapine side effect was reported by a Physician from JAPAN on Mar 19, 2008. Female patient, 35 years of age, weighting 92.59 lb, was diagnosed with depression
, hyperlipidaemia, insomnia and was treated with Olanzapine. After drug was administered, patient experienced the following side effects: anorexia nervosa, blood creatine phosphokinase increased, chromaturia, hyperlipidaemia, myoglobin blood increased, myoglobin urine present. Olanzapine dosage: 3 MG, DAILY (1/D). During the same period patient was treated with PAXIL, CRESTOR, DORAL, SILECE, MYSLEE. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #5373934-1
Olanzapine side effect was reported by a Physician from ITALY on June 15, 2007. Male patient, 25 years of age, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, pyrexia, staphylococcal infection
. Olanzapine dosage: 20 MG, DAILY (1/D). During the same period patient was treated with CLONAZEPAM, HALOPERIDOL, LORAZEPAM. Patient was hospitalized. Patient recovered.Olanzapine Side Effects Report #5254811-3
Olanzapine side effect was reported by a Physician from UNITED KINGDOM on Feb 19, 2007. Female patient was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, convulsion, depressed level of consciousness, haemodynamic instability, hypotension, intentional overdose, tachycardia. Olanzapine dosage: 50 MG, UNK. During the same period patient was treated with PHENELZINE. Patient was hospitalized. Patient died.
Olanzapine Side Effects Report #4788227-0
Olanzapine side effect was reported by a Pharmacist from UNITED STATES on Oct 04, 2005. Male patient, weighting 167.7 lb, was treated with Olanzapine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Olanzapine dosage: 5 MG BID PO. Patient was hospitalized. Patient recovered.